Charles Clausen recently posted on “The Prostate Problems Mailing List” the following about Transdermal Estradoil vs. LH-RH Agonists for Androgen Deprivation Therapy. I am planning to take a copy of this document with me to my next appointment with my Oncologist. “Richard Wassersug, a biology professor (and Psychology from the Department of Anatomy and Neurobiology) [...]
Once again, the prostate cancer community has been rocked by startling and conflicting news. According to a research study from The Johns Hopkins School of Medicine androgen deprivation therapy (hormone blockade- ADT) may encourage prostate cancer cells to produce Nestin, a protein that makes prostate cancer cells more likely to spread through out the body! [...]
Many of us struggle in our attempt to communicate with our doctors. One of the problems is that we just forget to ask all of our questions. We get into the examining room after waiting extended periods of time, the doctor comes whirling into the room with arm loads of records (most of which are [...]
Dr. Wassersug, a professor of anatomy at Dalhousie University in Halifax, and a prostate cancer survivor often gives lectures about advanced prostate cancer. He opens his lectures by asking a provocative question: "Who in our modern society is castrated? The answer invariably comes back loud and clear: sex offenders. Someone may venture another guess: transsexuals? [...]
At the recent Department of Defense Impact Conference Nicholas Bruchovsky, M.D., Ph.D., of Vancouver General Hospital and the University of British Columbia reported that an intermittent androgen blockade appears to delay the progression from treatable androgen-dependent cancer to untreatable androgen-independent disease. There has been an on going discussion about the difference in efficacy between a [...]